Overall rank by patents
#7,417
Across all tracked assignees
USPTO PatentsView assignee record - 44 granted patents across 24 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C02F (TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE).
The verdict
Gradiant holds 44 US patents across 24 technology areas, rank #7,417 of 50,000 tracked assignees.
Gradiant Corporation has been granted 44 US utility patents between 2015 and 2025, placing Gradiant Corporation at rank #7,417 across all assignees tracked by PlainPatent. This portfolio spans 24 distinct Cooperative Patent Classification (CPC) subclasses, averaging 23.0 claims per patent with primary concentration in C02F (TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE). As a US Corporation, Gradiant Corporation is one of the more focused assignees in the PatentsView dataset. By volume, Gradiant sits between Ganymed Pharmaceuticals Gmbh (44 patents, rank #7,413) and Hydac Fluidtechnik Gmbh (44 patents, rank #7,421) - the closest US assignees by grant volume. The composite Innovation Score of 46.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 14 grants, compared with 30 in the 2015–2019 window, a -53% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Gradiant Corporation's 23.0 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 24 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Gradiant Corporation against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Ganymed Pharmaceuticals GmbH
44 patents
Gemtek Technology Co., Ltd.
44 patents
Glowforge Inc.
44 patents
Grabango Co.
44 patents
HAWE Hydraulik SE
44 patents
HOCHIKI Corporation
44 patents
HUNAN BRUNP EV RECYCLING CO., LTD.
44 patents
HYDAC FLUIDTECHNIK GMBH
44 patents
Gradiant Corporation
44 patents
What this shows Gradiant holds 44 patents at rank #7,417, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #7,417 in granted patent volume.
Other assignees with the most granted patents in Gradiant's primary technology class.
Gradiant's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
46 Top 22% higher than 78% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 6.8% |
| 2016 | 3 | 6.8% |
| 2017 | 4 | 9.1% |
| 2018 | 5 | 11.4% |
| 2019 | 15 | 34.1% |
| 2020 | 3 | 6.8% |
| 2021 | 4 | 9.1% |
| 2022 | 3 | 6.8% |
| 2023 | 2 | 4.5% |
| 2024 | 1 | 2.3% |
| 2025 | 1 | 2.3% |
Top 15 of 24 technology areas
Overall rank by patents
#7,417
Across all tracked assignees
46.1 out of 100
How to use this portfolio
Gradiant's 44 grants land it in the top 22% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.